Volume 17, Issue 2 (February 2019 2019)                   IJRM 2019, 17(2): 135-142 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kemal Harzif A, Haloho A, Silvia M, Pratama G, Purwosunu Y, Wibawa A, et al . Trans-arterial embolization of acquired uterine arteriovenous malformation after Cesarean section: A case series. IJRM 2019; 17 (2) :135-142
URL: http://ijrm.ir/article-1-1404-en.html
Trans-arterial embolization of acquired uterine arteriovenous malformation after Cesarean section: A case series
Achmad Kemal Harzif * 1, Agrifa Haloho2 , Melisa Silvia3 , Gita Pratama4 , Yuditiya Purwosunu5 , Aria Wibawa5 , Prijo Sidipratomo6 , Jacub Pandelaki6
1- Division of Immuno-Endocrinology and Fertility, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia , kemal.achmad@gmail.com
2- Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia
3- Indonesian Reproductive Medicine Research and Training Center, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia
4- Division of Immuno-Endocrinology and Fertility, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia
5- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia
6- Department of Radiology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia
Abstract:   (10101 Views)
Background: Acquired uterine arteriovenous malformation (AVM) is a rare condition due to traumatic episodes in cesarean section. The patient can suffer from lifethreatening hemorrhage or recurrent vaginal bleeding. Establishing this diagnosis is difficult, often misdiagnosed due to lack of information and number of cases. Trans-Arterial Embolization (TAE) procedure is rarely performed in our center. All of the cases were found with history of massive bleeding and diagnosed lately after recurrent bleeding history. Even though promising, one of our cases failed to be managed with TAE. It is important to diagnose early symptoms of AVM in order to prevent the life threatening event.
Case presentation: In these case series, four cases of AVMs after cesarean procedures will be reviewed. One could be diagnosed in less than a month but the other three took several months. The symptom of vaginal bleeding might occur a few weeks after the procedure is done, and most patients need transfusion and hospitalization. Three out of four patients were initially sent to the hospital in order to recover from shock condition, and one patient was sent for a diagnostic procedure. AVMs diagnostic was established with ultrasound with or without angiography. Three of our cases were succeeded by
performing TAE procedure without further severe vaginal bleeding. One case failed to be treated with embolization and had to proceed with hysterectomy.
Conclusion: AVM should be considered early-on in patient with abnormal uterine bleeding and history of cesarean section. Embolization is still the first-choice treatment of AVMs, otherwise definitive treatment is hysterectomy in a patient without fertility need, or impossible to perform TAE.
Keywords: Trans-arterial embolization, Acquired uterine arteriovenous malformation, Cesarean section
Full-Text [PDF 6122 kb]   (1286 Downloads) |   |   Full-Text (HTML)  (506 Views)  
Type of Study: Original Article |
References
1. [1] Yoon DJ, Jones M, Taani JA, Buhimschi C, Dowell JD. A systematic review of acquired uterine arteriovenous malformations: pathophysiology, diagnosis, and transcatheter treatment. AJP Rep 2016; 6: e6–e14. [DOI:10.1055/s-0035-1563721]
2. [2] Katimada Annaiah T, Kodakkattil Sreenivasan S. Uterine arteriovenous malformations: clinical implications. Obstet Gynaecol 2015; 17: 243–250. [DOI:10.1111/tog.12218]
3. [3] Moshiri M, Osman S, Bhargava P, Maximin S, Robinson TJ, Katz DS. Imaging evaluation of maternal complications associated with repeat cesarean deliveries. Radiol Clin North Am 2014; 52: 1117–1135. [DOI:10.1016/j.rcl.2014.05.010]
4. [4] Scribner D, Fraser R. Diagnosis of acquired uterine arteriovenous malformation by doppler ultrasound. J Emerg Med 2016; 51: 168–171. [DOI:10.1016/j.jemermed.2016.04.028]
5. [5] Clarke JA, Viswanatha RK, Hamid R, Sankaranarayanan S. Diagnosis and management of life-threatening hypermenorrhagia caused by uterine arteriovenous malformation secondary to surgical termination of pregnancy: video evidence. BMJ Case Rep 2012; 2012: doi: 10.1136/bcr-2012-007368. [DOI:10.1136/bcr-2012-007368]
6. [6] Akbayir O, Gedikbasi A, Akyol A, Ucar A, Saygi-Ozyurt S, Gulkilik A. Cesarean scar pregnancy: a rare cause of uterine arteriovenous malformation. J Clin Ultrasound 2011; 39: 534–538. [DOI:10.1002/jcu.20848]
7. [7] Barber Jr JT, Tressler TB, Willis GS, Martinez FJ, Peisner DB, Goodman JD, et al. Arteriovenous malformation identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy. Am J Obstet Gynecol 2011; 204: e4–e8. [DOI:10.1016/j.ajog.2011.01.001]
8. [8] Chang KH, Park JK, Park SH, Kim HB, Park ST. Uterine arteriovenous malformation caused by intrauterine instrumentation for laparoscopic surgery due to left tubal pregnancy. Obstet Gynecol Sci 2014; 57: 419–423. [DOI:10.5468/ogs.2014.57.5.419]
9. [9] Laifer-Narin SL, Kwak E, Kim H, Hecht EM, Newhouse JH. Multimodality imaging of the postpartum or posttermination uterus: evaluation using ultrasound, computed tomography, and magnetic resonance imaging. Curr Probl Diagn Radiol 2014; 43: 374–385. [DOI:10.1067/j.cpradiol.2014.06.001]
10. [10] Rossi UG, Torcia P, Cariati M. Uterine arteriovenous malformation. Vasc Med 2016; 21: 473–474. [DOI:10.1177/1358863X16634195]
11. [11] Farias MS, Santi CC, Lima AA, Teixeira SM, De Biase TC. Radiological findings of uterine arteriovenous malformation: a case report of an unusual and life-threatening cause of abnormal vaginal bleeding. Radiol Bras 2014; 47: 122–124. [DOI:10.1590/S0100-39842014000200016]
12. [12] Aslan H, Acar DK, Ekiz A, Kaya B, Sezer S, Ismayilzade R, et al. Sonographic features and management options of uterine arteriovenous malformation. A case report. Med Ultrason 2015; 17: 561–563.
13. [13] Aiyappan SK, Ranga U, Veeraiyan S. Doppler sonography and 3D CT angiography of acquired uterine arteriovenous malformations (AVMs): report of two cases. J Clin Diagn Res 2014; 8: 187–189.
14. [14] Akashi K, Tanno K, Chikazawa K, Mikami Y, Netsu S, Konno R. Expectant management of a case of uterine arteriovenous malformation with an ovarian artery aneurysm. J Obstet Gynaecol Res 2016; 42: 579–583. [DOI:10.1111/jog.12941]
15. [15] Levy-Zaubermann Y, Capmas P, Legendre G, Fernandez H. Laparoscopic management of uterine arteriovenous malformation via occlusion of internal iliac arteries. J Minim Invasive Gynecol 2012; 19: 785–788. [DOI:10.1016/j.jmig.2012.07.009]
16. [16] Katano K, Takeda Y, Sugiura-Ogasawara M. Conservative therapy with a gonadotropin-releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease. Clin Case Rep 2015; 3: 479–482. [DOI:10.1002/ccr3.233]
17. [17] Morikawa M, Yamada T, Yamada H, Minakami H. Effect of gonadotropin-releasing hormone agonist on a uterine arteriovenous malformation. Obstet Gynecol 2006; 108:751–753. [DOI:10.1097/01.AOG.0000191584.28717.2c]
18. [18] Khatree MH, Titiz H. Medical treatment of a uterine arteriovenous malformation. Aust NZ J Obstet Gynaecol 1999; 39: 378–380. [DOI:10.1111/j.1479-828X.1999.tb03424.x]
19. [19] Kaump GR, Spies JB. The impact of uterine artery embolization on ovarian function. J Vasc Interv Radiol 2013; 24: 459–467. [DOI:10.1016/j.jvir.2012.12.002]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb